Stay updated on Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.

Latest updates to the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page
- CheckyesterdayChange DetectedThe site shows a new Revision: v3.6.6, replacing the previous Revision: v3.6.5. This reflects an updated build/version of the page.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a platform/internal update. There is no alteration to the study content, eligibility criteria, or results.SummaryDifference0.0%

- Check29 days agoChange DetectedThe page’s Related Topics section has been trimmed to remove the melanoma topic tag, the related topics header, and the MedlinePlus Genetics link.SummaryDifference0.1%

- Check36 days agoChange DetectedMelanoma and MedlinePlus Genetics are added as related topics on the page. The page revision tag has been updated to v3.6.4, replacing the previous v3.6.3.SummaryDifference0.2%

- Check44 days agoChange DetectedMelanoma was removed from the related topics section and the related topics header, and the MedlinePlus Genetics link was removed. This changes how the study's disease context and related informational resources are presented on the page.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded Melanoma as a related topic and linked MedlinePlus Genetics. Updated the page revision to v3.6.3 (replacing v3.6.2).SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.